Liao Chengsong, Han Yangyang, Chen Zhijing, Baigude Huricha
Xilingol Institute of Bioengineering, Xilingol Vocational College, 11 Mingantu Road, Xilinhot, 026000, Inner Mongolia, People's Republic of China.
School of Chemistry & Chemical Engineering, Inner Mongolia University, 235 Daxue West Road, Hohhot, 010021, Inner Mongolia, People's Republic of China.
Allergy Asthma Clin Immunol. 2021 Sep 7;17(1):87. doi: 10.1186/s13223-021-00587-6.
A formulation of black cumin (Nigella sativa L.), licorice (Glycyrrhiza glabra L.), anise (Pimpinella anisum L.) and tea (Camellia sinensis (L.) Kuntze) (denoted BLAB tea) is traditionally used to relief allergy reaction including allergic rhinitis. However, little is known about its underlining mechanism of anti-allergic effects.
To investigate the anti-allergenic mechanism of BLAB tea, we treated ovalbumin (OVA)-induced allergic rhinitis (AR) model of mice with BLAB tea, and elucidated its possible mechanism of action. Mice in the control group were treated with phosphate-buffered saline only. Subsequently, the infiltration of different inflammatory cells was measured. In addition, histopathological changes in the nasal mucosa, and the levels of allergen-specific cytokines and OVA-specific immunoglobulins were measured.
The aqueous extract of BLAB significantly alleviated the nasal symptoms and reduced the accumulation of inflammatory cells in the nasal mucosa and nasal lavage fluid of AR model of mice.
The aqueous extract of BLAB induced the production of Th1 and Treg cytokines and inhibited the release of Th2 cytokines and histamine in nasal mucosa and serum of mice while decreasing the serum levels of OVA-specific IgE, IgG1, and IgG2a. These results suggest the potential of the aqueous extract of BLAB as a treatment option for allergic diseases.
黑种草(Nigella sativa L.)、甘草(Glycyrrhiza glabra L.)、茴芹(Pimpinella anisum L.)和茶(Camellia sinensis (L.) Kuntze)(简称BLAB茶)的一种配方传统上用于缓解包括过敏性鼻炎在内的过敏反应。然而,其抗过敏作用的潜在机制却鲜为人知。
为了研究BLAB茶的抗过敏机制,我们用BLAB茶处理卵清蛋白(OVA)诱导的小鼠过敏性鼻炎(AR)模型,并阐明其可能的作用机制。对照组小鼠仅用磷酸盐缓冲盐水处理。随后,测量不同炎症细胞的浸润情况。此外,还测量了鼻黏膜的组织病理学变化以及过敏原特异性细胞因子和OVA特异性免疫球蛋白的水平。
BLAB的水提取物显著减轻了小鼠AR模型的鼻部症状,并减少了鼻黏膜和鼻腔灌洗液中炎症细胞的积聚。
BLAB的水提取物诱导小鼠鼻黏膜和血清中Th1和Treg细胞因子的产生,抑制Th2细胞因子和组胺的释放,同时降低血清中OVA特异性IgE、IgG1和IgG2a的水平。这些结果表明BLAB水提取物作为过敏性疾病治疗选择的潜力。